Skip to main content
Premium Trial:

Request an Annual Quote

Green Access at Science

The publisher of the Science family of journals will allow some authors to place peer-reviewed versions of their papers into publicly accessible repositories, according to Science's news team.

It adds that the scheme applies to researchers with funding from a group of mostly European research funding organizations, though also others like the Bill & Melinda Gates Foundation. The group launched Plan S in 2018 with the aim of requiring publicly funded researchers to make their journal articles freely available upon publication.

The initiative's requirements went into effect this month, as Science previously reported. That spurred a November announcement from Springer Nature that it would be offering authors an open-access option, though Science noted that Springer Nature's fee of €9,500 (US $11,390) is higher than other journals' price tags.

American Association for the Advancement of Science says it will pilot this new program for a year to monitor how it affects its revenue flow. 

Science adds that this open-access model is dubbed green open access and that if AAAS had pursued a gold open access approach in which authors pay a fee to make their papers immediately available, the cost likely would have been as high as or higher than Springer Nature's fee and prohibitive for many researchers. 

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.